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Prolonged uncontroled hypertension is known to cause renal impairment . 
The precise mechanism by which raised systemic blood pressure leads to renal 
impairment is unclear. Free radicals have been implicated in cell damage and 
hypert~nsive has been shown to have higher level of plasma lipid peroxidation 
end product malondialdehyde (N.IDA) than normal individuals . This study 
· aims to ascertain the levels ofMDA in spontaneously hyp,ertensive rats (SHR) 
and determine the age at which changes in the levels ofMDA and renal 
impairment begin to occur in SHR. 
----·----Sixty-six r;nale SHR, aged 8 weeks~-were divided into eleven groups. A similar 
number of male Wistar Kyoto rats (WKY) were also similarly divided to act as 
parallel controls. Body weight , systemic blood pressure and plasma ~A were 
measured every four \¥eeks starting from the age of 8th weeks until the age of 
48th week. Plasma MDA was measured using High Performance Liquid 
Chromatography (HPLC). Every four weeks, six rats per group were 
anaesthetized for measurement of Glomerular Filtration Rate (GFR), using 
standard clearance procedures, to assess the renal function. 
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Mean body weight of SHR was consistently lower than that ofWKY rats from 
th·e ·age of 12 weeks onwards (p < 0.05). Blood pressure, on the other hand, was 
significantly higher in the SHR when compared to that in age-matched WKY rats 
from the age of8 weeks onwards (p < 0.05). Interestingly, plasma MDA levels 
was higher in the SHR than in the controls only from the age of 12 weeks, 
reaching statistical significance by the age. of24, 44 and 48 weeks. GFR was 
lower in 'SHR from t he age of24 weeks onwards (p .. <0.05). It appears that there 
is an age-related decline in GFR in SHR, implying renal impairment , particularly 
from the age of24 weeks onwards when compared to WKY rats but plasma MDA 
levels was higher in the SHR than in the controls from the age of 12 weeks. It is 
unclear if the decrease in GFR is a result of the raised levels ofMDA, but it 
appears that renal impairment occurs subsequent to changes in plasma MDA 
levels. Clearly, more studies are needed to ascertain the relationship between the 
changes in GFR and MDA in hypertension. 
(Abstrak dalam Bahasa Malaysia) 
Adalah umum diketahui hipertension tak terkawal yang berpanjangan boleh 
menyebabkan·gangguan/kerosakan fungsi renal. Mekanisme yang tepat 
bagaimana tekanan d~rah yang tinggi boleh menyebabkan kerosakan ginjal 
masih bel urn jelas. Radikal bebas telah disabitkan dengan proses kerosakan sel 
dan pesakifhipertension i:iidapati mempunyai aras plasma malondialdehid 
(MD A) yang lebih tinggi berbanding individu normal. Kajian ini bertujuan untuk 
menentukan aras l\IIDA dalam tikus hipertensif spontaneous (SHR) dan umur 
tikus di mana perubahan kepada aras :MDA dan kerosakan fungsi ginjal berlaku. 
Enam puloh enam tikus jantan SHR, berumur 8 minggu, dibahagikan kepada 
sebelas kumpulan. Jurnlah yang sama tikus jantan Wistar Kyoto (WKY) juga 
dibahagikan kepada sebelas kumpulan sebagai mewakili kumpulan kontrol. Berat 
badan, tekanan darah dan plasma :NIDA diukur setiap .empat minggu dari tikus 
mula berumur 8 rninggu sehingga berumur 48 minggu. Aras plasma MDA diukur 
dengan menggunakan kaedah 'High Performance Liquid Chromatography' 
(HPLC): Setiap empat rninggu, enam tikus dalam setiap kumpulan dibius untuk 
penentuan Kadar Penurasan Glomerulus (G~R), menggunakan kae9ah penurasan 
piawai, '-;lntuk menilai fungsi ginjal. 
Berat badan min SHR didapati secara konsisten lebih rendah daripada tikus WKY 
.- ---~dari_mula_herumur 12 minggu dan seterusnya ( p <0.05). Tekanan darah ttkus 
----- SHR adal.ah lebih tingg1 dari tikus WKY yang sama umur bermula dari umur 
tikus 8 rni~ggu da·n seterusnya (p < 0.05) . Aras plasma l\1DA adalah lebih tinggi 
dalam tikus SHRjika dibandingkan dengan kumpulan tikus kontrol bermula dari 
umur 12 minggu, dan mencapai tahap signifikan statistik pada umur tik:us 24, 44 
dan 48 minggu. GFR adalah lebih rendah dalam tikus SHK bermula dari umur 
24 rninggu dan seterusnya (p <0.05). Didapati bahawa nilai GFR pada tikus SHR 
menurun mengikut umur , menandakan gangguan/kerosakan fungsi ginjal, 
bermula dari umur 24 rninggu jika dibandingkan dengan tikus WKY, tetapi 
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aras plasma MDA tikus SHR adalah lebih tinggi jika dibandingkan dengan 
kontro.l ber!Jlula dari umur tikus 12 minggu. Adalah tidak pasti penurunan nilai 
GFR pada tikus SHR adalah akibat dari peningkatan· aras MDA', tetapi· · 
nampaknya gangguan/kerosakan ginjal berlaku selepas berlaku peningkatan aras 
.MD A. Adalah jelas, banyak lagi kajian perlu dijalankan untuk mengetahui kaitan/ 
perhubongan di antara perubahan GFR dan .MDA_dalam hipertension. 
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Abstract: 
Compared to normotensives, hypertensives and patients with renal failure have 
higher levels of plasma malondialdehyde (MDA) and unnary 8-epi-prostaglandin F2a. 
The exact significance of the raised levels of :MD A and urinary 8-epi-prostaglandin F2a 
activity in hypertension is unclear. It is however unclear if they are involved in the 
pathogenesis of hypertension or are a consequence of hypertension. This study attempts 
to ascertain the age at which changes in blood pressure, levels of plasma 1\IDA, urinary 
8-epi-prostaglandin F2a and renal impairment begin to occur in Spontaneously 
I-Iypertensive rats (SHR). 
Sixty-six, 8-week old Spontaneously Hypertensive Rats (SHR) were divided 
equally into eleven groups with age-matched Wistar-Kyoto rats (WKY) as controls. 
Every 4 weeks, blood pressure was recorded by the tail-cuff method on six SHR and six 
WKY rats. After the measurement of blood pressure, the rats were then individually 
housed in metabolic cages for collection of 24-hr urine samples for 8-epi-prostaglandin 
. F2a and urine electrolyte determinations and from 36 to 48 weeks onwards for the 
measurement of food and water intake. After the urine collection the rats were 
anaesthetised for measurement of glomerular filtration rate (GFR) using a standard 3H-
inulin clearance protocol. Immediately upon completion of the measurement of 
glomerular filtration rate, the animals were exsanguinated for the determination of plasma 
malondialdehyde levels. 
Mean body weight of SHR was consistently and significantly lower than that of 
WKY rats from the age of 12 weeks onwards (p<O.Ol). Systolic blood pressure was 
significantly higher in the SHR when compared to those in age-matched WKY rats from 
the age of 8 weeks onwards (p<O.Ol). Plasma MDA and urinary 8-epi-prostaglandin F2a 
were all significantly higher in SHR when compared to the controls from the age of 16 
and 12 weeks onwards respectively (p<0.05 for :MDA; p<O.Ol for 8-epi-prostaglandin 
F2a). GFR was significantly lower (p<0.05) in SHR from the age of 28 weeks onwards 
when compared with age-matched normotensive WKY rats. No significant differences 
were noted in plasma creatinine concentrations between the two groups throughout the 
study period. 
In conclusion, it seems, evidence for increased free radical activity appears four to 
six weeks after the development of hypertension in SHR rather than the cause of it. In 
addition, as renal impairment only becomes evident after changes in free radical activity, 
increased free radical activity might have a role in some of the complications associated 
with hypertension. 
Keywords: Free radicals, hypertension, renal impairment, :MDA, urinary 8-epi-
prostaglandin F2a, SHR. 
Introduction 
Free radicals are unstable, reactive normal products of cellular metabolism 1• Due to their 
high reactivity, free radicals can cause severe damage to biological molecules, especially 
to lipids, DNA and protein 2. All cells either generate or make use of a variety of lipid or 
water-soluble antioxidant compounds (Vitamins E, C, A, gluthathione etc), and 
synthesise a series of antioxidant enzymes (catalase, superoxide dismutase, gluthathione 
peroxidase), which are responsible for deactivating these reactive intermediates of 
oxygen. Under normal conditions, there exists a fine balance between free radical 
production and antioxidant defence systetn such that little damage results to the cells. 
An imbalance between free radical production and antioxidant activity, often referred to 
l:LS oxidative stress, has been implicated in cardiovascular 3•4•5•6•7 and renal diseases8•9•10. 
There is abundant evidence implicating oxidative stress in various animal models of 
hypertension. Vascular 02·- is increased in the DOCA-salt 11' 12 , angiotensin IT-infusion 
13
•
14 
, and 1-kidney 1-clip 15 models of hypertension. Increased activity of NAD(P)H 
oxidase in angiotensin II-induced hypertension has been shown to activate NAD(P)H 
oxidase by up-regulating p22phox mRNA levels, and infusion of recombinant heparin-
binding superoxide dismutase (SOD) decreased both blood pressure and p22phox mRNA 
expression 16. Administration of heparin-binding SOD within the vessel wall has been 
shown to normalise partially the blood pressure of the SHR. 12' 17. Interestingly, 
norepinephrine-induced hypertension does not increase 02·- production or oxidase 
expression suggesting that 02·- could be variably involved in the syndrome of 
hypertension 14. Despite of the considerable evidence implicating oxidative stress in 
hypertension, the point of time when there occurs a detectable change in free radical 
production or oxidative stress remains unclear. Whether it occurs before the 
development of hypertension or along with the development of hypertension or sometime 
after the establishment of hypertension has still to be clearly established. Suzuki et al 18 
showed an increased generation of 0 2·- in arterioles and venules in SHR. Wu et al 19 
noted that NADH stimulated 0 2·- production in cultured smooth cells (SMCs) from 6-
week old SHR was not different from SMCs from age-matched Wistar-Kyoto rats.· 
:{fowever, 0 2·- production was significantly higher in SMCs from 9 and 12 week old SHR. 
when compared to that in SMCs from age-matched Wistar Kyoto rats. Incidentally, 
hypertension is usually well established in SHR by the time they reach 9 -12 weeks of 
age. These observations imply that hypertension either precedes or occurs concomitantly 
with the oxidative stress. 
Prolonged uncontrolled hypertension often results in renal impairment in humans. The 
precise mechanism by which raised systemic blood pressure leads to renal impairment is 
still unclear. High levels of lipid peroxidation activity has been reported in patients with 
chronic renal failure 20'21 '22. Besides, reactive oxygen species (ROS) like hydrogen 
peroxide 23 and superoxide radicals 24 have been shown to cause tubular and glomerular 
damage. Although, hypertensives have been shown to have higher levels of oxidative 
stress, as indicated by raised levels of lipid peroxidation end products like 
malondialdehyde (MDA) 25'26 and 8-epi-prostaglandin F2a. 27'28'29 and lower levels of 
antioxidant activity 30'31, it remains unclear how long after the increased oxidative stress 
that significant renal damage becomes apparent. Animal studies looking at the time point 
changes in oxidative stress and the development of hypertension in SHR and its renal 
complications are lacking. The purpose of this study therefore was to investigate the time 
point at which evidence for increased oxidative stress becomes apparent in hypertension, 
and whether renal function precedes or follows this change in oxidative stress in 
Spontaneously Hypertensive Rats (SHR), using plasma l\IDA and urinary 8-epi-
prostaglandin F2a. as markers of oxidative stress. 
Material and Methods 
Sixty-six, 8-week old Spontaneously Hypertensive Rats (SHR) were divided equally into 
eleven groups. A similar number of age-matched Wistar-Kyoto rats (WKY) were 
similarly divided to act as corresponding controls. All animals were exposed to a similar 
light-dark cycle and had access to food and water ad libitum. Every 4 weeks, blood· 
pressure was recorded by the tail-cuff method on six SHR and six WKY rats. After the 
measurement of blood pressure, the rats were then individually housed in metabolic cages 
for a period of 5 days. The animals were allowed to adapt to the metabolic chambers for 
the first two days. For the next three days afterwards, 24-hr urine samples were collected 
for 8-epi-prostaglandin F2a and urine electrolyte determinations. After the last urine 
collection, rats were allowed to recover for 24 hours before they were anaesthetised for 
measurement of glomerular filtration rate (GFR) using a standard 3H-inulin clearance 
protocol for anaesthetised animals. Immediately upon completion of the measurement of 
glomerular filtration rate, the animals were exsanguinated for the determination of plasma 
malondialdehyde levels. 
f -
l 
Blood pressure measurement 
Arterial blood pressure was measured by tail plethysmography (Life Science, IITC, USA). 
To help reduce anxiety in the animals during the measurement of blood pressures, all 
animals, from the age of 5 weeks, were handled daily and repeatedly exposed to a 
perspex cylindrical animal holder used to restrain the animals during the measurement of 
blood pressure. During the actual measurement, conscious rats were first placed under 
an angle-poised lamp for 10 minutes to ensure good tail blood circulation before being 
placed inside an animal holder in a chamber, where the temperature was maintained at 32 
± 0.5 °C, for the tneasurement of blood pressure. Rats were allowed to rest inside the 
chamber for a period of ten minutes before blood pressure measurements were obtained. 
On each occasion three consecutive measurements were recorded using a physiograph 
(NARCO BIO SYSTEM, USA), and a mean of three measurements was recorded. 
Determination of glomerular filtration rate 
Glomerular filtration rate was estimated using 3H-Inulin clearance as previously 
described 32• Briefly, after an overnight fast, but with access to water ad libitum the rats 
were anaesthetized with an intraperitoneal injection of thiopentone sodium (ROTEX, 
USA), at a dose of ~0 mg/kg body weight. After anesthetization, the rats were transferred 
to a preheated thermostat controlled animal operating table. A mercury thermometer was 
introduced into the rectum to monitor the body temperature throughout the procedure. 
The left jugular vein, for saline infusion, and right carotid artery were cannulated for 
~aline infusion and the recording of blood pressure and blood collection respectively. A 
tracheotomy was performed to keep the airway clear. A bolus of0.03 ml of normal saline 
containing 20Jl Ci mr1 of 3H Inulin (AP Biotech, England) was injected into the jugular 
vein. This was followed by an infusion of normal saline at the rate of 100J.ll min-1, 
containing 1 fl Ci ml-1 of 3H-Inulin. Urinary bladder was cannulated suprapubically for 
collection of urine samples. After an equilibration phase of 2 hours, samples of arterial 
blood and urine were obtained every 30 minutes for one hour. Arterial blood (100J.Ll) was 
collected in heparinized hematocrit tubes and following centrifugation, plasma was 
retained for measurement of 3H-Inulin. Urine and plasma 3H-Inulin activities were 
estimated using a f3 scintillation counter (Packard, TRI-CARB 31 OOTR, USA). 
Measurement of plasma MDA 
Plasma MDA was quantified using High performance liquid chromatography (HPLC) as 
described previously, 33•34'35 using a Micro-Tech HPLC system (Micro - Tech 
Instrument, model 200M, USA) consisting of a Micro -Tech HPLC pump (M -PMOD) 
with a 50J.LL injection loop, and a ·uv detector (Linear Instrument, modal200, USA) was 
used. The column was a LiChroCART ® 250-4, packed with 5 mm LiChrospher I 00 RP-
18 (Merck). It was equipped with a guard column: LiChroCART 4-4 packed with 5 mm 
LiChrospher 100 RP-18. The elution was carried out at a flow rate of0.5 ml min-1. The 
mobile phase consisted of 10 mmol L-1 potassium dihydrogen phosphate (pH 6.0) and 
methanol (BDH, UK) in a ratio of 60: 40 by volume. The column effiuent was quantified 
at a wave-length of 532 nm. After thawing, lOOJ.Ll of plasma was added into a 5 ml Pyrex 
centrifugation tube containing 700J!l of 1% orthophosphoric acid (Merck, German) and 
then vortex-mixed for 10 seconds. 200J.Ll of 42 mmol/L 2-TBA solution (Merck, German) 
was then added, and vortex-mixed for another 10 seconds. The sample was then heated in 
a water bath at 100 oc for 60 minutes. Hereafter, the sample was kept on ice until I o 
minutes before HPLC analysis. At the time of analysis the sample was vortex-mixed for 
10 seconds, and 200J.tl of it was transferred into a 2 ml tube containing 200J.tl of 1:12 (by 
volume) 2 mol L-1 sodium hydroxide (Merck, German): methanol solution. The sample 
was vortex-mixed for 10 seconds and centrifuged for 3 minutes at 13,000 rpm and 200J..Ll 
of the supernatant was transferred to a 300J.ll glass vial and 50J.tl of this solution was 
injected into the column and absorbance measured at 532 nm. MDA standard solution 
was prepared from 1,1,3,3-Tetraethoxypropane (TEP) (Sigma, USA) by serial dilution 
with the concentrations of 5J..Lmol!L, 2.5J.lmol/L, 1.25J.lmol/L and 0.625J..Lmol!L. l\IDA 
standard concentration was plotted against the area under the curve. The concentration of 
each sample was identified on the standard curve and read from the corresponding values 
on the y-axis (MDA standard concentration). 
Urine 8-~pi-prostaglandin F2a. was measured using commercially available 8-Isoprostane 
EIA Kit (Cayman, USA). 
Statistical analysis was performed using repeated measures-ANOVA and Student's t test. 
All results are presented as mean ± standard error of mean and a 'p' of <0.05 was 
considered significant. 
Results 
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Figure 1: Body weight in age-matched SHR and WKY rats. 
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No significant difference was evident in body weight between the two groups at the age 
of 8 weeks (Figure 1). Body weight increased significantly in both groups over the 
period of study. The rate of increase was somewhat greater up to about twenty weeks of 
age, particularly in the WKY rats, after which the rate of increase became slower. From 
the age of 12 weeks, however, WKY rats were significantly heavier than age-matched 
SHR. The body weight of SHR was about 78% of their WKY counterparts at the age of 
48 weeks. 
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Figure 2: Daily food intake between 36 and 48 weeks in SHR and WKY rats 
Food intake in both groups averaged between 15 - 25 grams per day over that period of 
study (Figure 2). There was no significant difference in food intake between the two 
groups. 
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Figure 3: Water intake between week 36 and 48 in SHR and WKY rats 
Water intake in both groups averaged between 25 - 30 ml per day over that period 
(Figure 3). There was no significant difference in water intake between the two groups. 
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Figure 4: Systolic blood pressure in age-matched in SHR and WKY rats. 
Mean systolic blood pressure in SHR was significantly higher from the age of 8 weeks 
onwards when compared to age-matched WKY rats (Figure 4). Although systolic blood 
pressures remained almost unchanged between the age of 8 and 48 weeks in WKY rats, 
in the SHR, however, systolic blood pressure appears to increase significantly with age 
until about the age of 20 weeks, remaining somewhat unchanged thereafter. Mean 
systolic pressures increased from a mean of 146 ± 7 mmHg at week 8 to a mean of212 ± 
8 mmHg at week 28 in the SHR. It remained within that level until the termination of the 
study at the age of 48 weeks. 
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Figure 5: Plasma lV.IDA levels in SHR and age-matched WKY rats. 
No signific.ant difference was evident in plasma lV.IDA levels between the two groups at 
the age of 8 weeks (Figure 5). However, plasma lV.IDA levels were higher in SHR from 
the age of 12 weeks reaching statistical significance from the age of 16 weeks onwards (p 
< 0.05). 
N 
LL 
c 
l::J 
c 
ro 
200 
175 
150 
-,-..... 
~ .E 125 
cne> §_ ~ 100 
I ro 
·a.li 75 
<I> ro 
I 
co 
I 
(!) 
c 
·c 
=:l 
50 
25 
0 
• SHR • \Nt<..Y 
8 12 16 20 24 28 32 36 40 44 48 
Age (weeks) 
*p<0.05; **p<O.Ol , ***p<O.OO l 
Figure 6 Mean urinary 8-epi-prostaglandin F2 alpha in SHR and age-matched WKY rats 
No significant difference was evident in urinary 8-isoprostane concentrations between 
the two groups at the age of eight weeks (Figure 6). However, urinary 8 - isoprostane 
concentration increased significantly in SHR from the age of 12 weeks (p<O.Ol) and 
remained within that levels until end of study at the age of 48 weeks. 
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Figure 7: Mean glomerular filtration rate (GFR) in SHR and age-matched WKY rats 
No significant difference was evident in glomerular filtration rate between the two groups 
up until the age of 24 weeks. However, glomerular fi ltration rate was significantly higher 
from the 28th - 48th week in WKY rats (Figure 7). The difference appears to be due to a 
slight age related increase in the WKY rats (r =0.422; p<O.Ol) and a slight age-related 
decrease in GFR in SHR (r = -0.424; p<O.O l). 
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Figure 8: Mean plasma creatinine concentration in SHR and age-matched WKY rats 
No statistically significant difference was evident in plasma creatinine levels between 
SHR and WKY rats (Figure 8). It also appears to have remained unchanged with age in 
both the groups. 
, 
Discussion 
There were three important observations of note in this study. Body weight of SHR was 
significantly lower than that in age-matched WKY rats from the age of 12 weeks onwards. 
In addition, there were significant differences in urinary excretion of 8-epi-prostaglandin 
F2 alpha and plasma :MDA between the two groups, which became evident from the age 
of 12 and 16 weeks .onwards respectively. More importantly, these differences only 
became evident after the establishment of high blood pressure in the SHR. The third 
important observation was the difference in GFR between the two groups, which became 
evident from the age of 28 weeks. 
Age related increase in body weight is a well-established and reported phenomenon even 
in adult rats 36'37'38'39. What has not often been reported is the tendency to a lower 
increase in body weight in SHR. Although body weight was not significantly different 
between the two groups at the age of 8 weeks, but from then onwards body weight of 
SHR was consistently lower than WKY rats (Figure I; p < 0.01). By the age of 48 weeks, 
body weight of SHR was about 78% of that in age-matched WKY rats. The precise 
reason for the differences in body weight is uncertain. Although food intake was only 
recorded between weeks 36 and 48, no significant difference was evident in food intake 
between the two groups {Figure 2). Two possibilities that could explain for the lower 
body weight in SHR include either impaired gastro-intestinal absorption of nutrients or 
the effect of increased stress or both. In this regard, significant ultrastructural and 
functional changes in the jejunal epithelium in SHR 40 have been reported and numerous 
studies in-vitro have shown impaired calcium 41•42 and glucose 43 absorption in SHR. 
Weight loss in rats exposed to repeated acute restraint stress has been reported 44'45 . The 
SHR in this study always appeared tensed and squeaked excessively during handling. 
Although the precise mechanism by which stress causes weight loss again remains 
unknown, there is evidence to suggest that the weight loss may be dependent upon acute 
central release of corticotropin-releasing factor 45, and leptin from the adipose tissue. 
Leptin secretion, which increases during stress in man 46 , is known to suppress appetite 
and food intake in rodents and man, in addition to increasing sympathetic activity and 
possibly metabolism . Serum leptin was not measured in this study. Although mean food 
intake was slightly lower in SHR (Figure 2), it however was not statistically significant. 
It therefore appears that the reason for the lower bodyweight is probably due to a 
combination of slight lower food intake, impaired gastrointestinal absorption and stress 
related increase in metabolic rate. 
At the age of 8 weeks, SHR were moderately hypertensive as evident by mean systolic 
pressure, which was 19% hig her than that in WKY rats (p<O.Ol) at this age (Figures 4). 
Systolic pressure remained unchanged from the age of 8 to 48 weeks of study in the 
WKY rats. In the SHR. however, systolic blood pressure increased significantly until 
about the age of 24 weeks after which it remained unchanged until the end of the study at 
the age of 48 weeks. The exact cause for the raised blood pressure in SHR remains 
unknown but similar results have also been reported before 36'38•47•48 . Increase peripheral 
resistance is a possible factor that results in the rai sed blood pressure, but what causes 
this remains unknown. The toxic effects of free radicals are now well recognised and 
altered free radical activity in hypertension has been reported in the rat 5•6•7 and man 
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or secondary to the hypertension. Plasma MDA concentration was not significantly 
different between SHR and WKY rats at the age of 8 weeks, although by that time the 
~ypertension was already evident in the SHR (Figure 5). In WKY rats, plasma :MDA 
levels were significantly lower by about 26% at 16 weeks when compared to 8-week old 
WKY rats. The levels remained unchanged thereafter in the rest of the groups. The reason 
for the lower levels from the age of 16 weeks in WKY rats is uncertain. In the SHR, 
however, plasma MDA levels were higher in all age categories above 12 weeks when 
compared to WKY rats, the difference reaching statistical significance from the age of 16 
weeks onwards (p < 0.05). It remained significantly higher thereafter for rest of the 
period of study. The reason for the higher plasma r.ADA levels in SHR is unclear. It is 
possible that there is either an increased production of free radicals and consequently 
their activity or a decrease in the natural antioxidant activity. Decreased antioxidant 
activity has been reported in patients with essential hypertension 26 and in hepatocytes 
from SHR 51 . A decrease in antioxidants could induce an increased cellular generation of 
radical species and lipid peroxidation. Of more interest however, is the time point at 
which changes in free radical activity became apparent in this study. The difference in 
plasma MDA between the two groups only became evident from the age of 16 weeks 
onwards. This is about 8 weeks after the establishment of hypertension. This finding 
therefore suggests that higher levels of lipid peroxidation and elevated free radical 
activity only become evident after the establishment of moderate to severe hypertension 
and not before. Whether the increased free radical activity is a result of the raised blood 
.. 
pressure per se or is an associated abnormality remains to be confirmed but our finding 
does, however, imply or postulate that the raised blood pressure is not a result of 
increased free radical activity or caused by oxidative stress. This postulation appears in 
contrast to numerous studies showing the benefits of antioxidant supplementation in the 
treatment of hypertension 7'39'47'52'53. Although supplementation of antioxidants like 
vitamin C, E, tempo I, lazaroid and PUF A reduced systemic arterial pressures in both rat 
and humans, it was interesting to note that in none of the studies the hypertension was 
completely ameliorated. The inference from this is that increased oxidative stress may not 
be the primary cause of hypertension, but elevated free radicals may play an important 
role in the maintenance of high blood pressure. 
No significant difference was evident in urinary 8-epi-prostaglandin F2a concentration 
between SHR and WKY rats ~t the age of 8 weeks (Figure 6). However, urinary 
concentration of 8-epi-prostaglandin F2a in 12-week old SHR was significantly higher, 
not only from their 8-week old counterparts but also when compared to age - matched 
WKY rats. Urinary concentration of 8-epi-prostaglandin F2a in the remaining SHR age-
categories remained the same to that in their 12-week old counterparts, it was 
nevertheless consistently and significantly higher in the SHR when compared to age -
matched WKY rats. The concentration of 8-epi-prostaglandin F2a was not different 
between the various ages-categories in the WKY rats. Raised urinary 8-epi-prostaglandin 
F2a has also been reported in SHR 
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, in patients with pulmonary hypertension 56, in 
patients with reno - vascular disease and essential hypertension 29, and in pigs with 
renovascular hypertension induced following unilateral renal occlusion 6. In addition 
' 
., 
hypertension secondary to chronic angiotensin II infusion in pigs has also been shown to 
increase plasma 8-epi-prostaglandin F2a. 27. As was the case with changes in MDA levels 
in this study, elevated urinary 8-epi-prostaglandin F2a. was only evident after 
establishment of hypertension in SHR. These observations suggest that the levels of 8-
epi-prostaglandin F2a, which is also an indicator of oxidative stress, may be a result of 
. 
raised systemic arterial pressure and not a cause of it. This is also supported by a recent 
observation where levels of urinary 8-epi-prostaglandin F2a. were increased only in 
moderate to severe hypertension, but not in mild hypertension 56. Although detectable 
changes in oxidative stress only became evident from the age of 12 weeks in this study, it 
is possible that increased production of free radicals may have occurred together or soon 
after the beginning of hypertension. Cultured smooth muscle cells from 9-week, but not 
from 6-week, old SHR were shown to have increased NADH stimulated superoxide 
production 19. The reason for the delay in the development of detectable oxidative stress 
could be due to concomitant increase in endogenous anti-oxidant activity. It is only when 
there is an imbalance between the rate of production of free radicals and anti-oxidant 
capacity, that oxidative stress appears. When taken together these observations and 
those from our study suggest that increased oxidative stress is not directly involved in the 
aetiology or pathogenesis of hypertension, at least not in the early stages, but sustained 
hypertension increases free radical activity. Once again it appears that free radicals may 
not be involved in the aetiology or pathogenesis of hypertension but may be involved in 
the maintenance of raised blood pressure. In this regards, vasoconstrictor effects of 8-
epi-prostaglandin F2 a. have been reported 57• 
., 
The consequences of raised blood pressure include cerebral vascular stroke and damage 
to organs like the heart and kidney. Precisely how the latter happens is unclear. They 
could be caused either by the raised blood pressure itself or by some co-existing 
abnormality in hypertension. When compared by age-categories, no significant 
difference in GFR was evident between SHR and WKY rats up to the age of about 24 
weeks (Figure 7). From the age of 28 weeks onward however, GFR was significantly 
tower in SHR when compared to WKY rats. Glomerular filtration rate in the SHR 
declined with progressive age categories from the age of 20 weeks, whereby at the age of 
48 weeks it was significantly lower than that in 8-week old SHR.. There was a negative 
correlation between GFR and age in SHR. In contrast, in the WKY rats GFR appeared to 
be rising or increasing with increasing age - categories. The reason for the differing GFR 
pattern in the WKY and SHR appears to be due to the hypertension as renal impairment 
only develops after several weeks of sustained hypertension. Our finding of a lower GFR 
in SHR is in contrast to observation of Tolbert et al 48, who found no significant 
difference in GFR between 3 6 week old SHR and WKY rats. The reason for the 
difference between this study and that of Tolbert et al 48 is not immediately apparent but 
it may be related to the clearance protocol used. In their study, Tolbert eta! had used 
very low infusion rates (0.5 ml/hr versus 6 ml/hr in our study) and shorter equilibration 
phase. The extracellular volume expansion was small in their study. Sufficient 
extracellular volume expansion is necessary to uncover latent renal impairment, as low 
volume challenges may not be sufficient to reveal the presence of such renal impairment 
at this stage of the hypertension. The finding of impaired renal function confirms the 
presence of this complication in SHR, albeit evident only when challenged with a high 
saline load. Not surprisingly, plasma creatinine concentration was not significantly 
different between the two groups at this stage (Figure 8). The reason for this is that the 
renal impairment was not sufficient at this stage to compromise renal function . under 
normal circumstances. It does however indicate of decreasing renal reserve which is 
progressive and would lead impaired renal function under normal circumstances. The 
precise mechanism by which hypertension impairs renal function is unclear. Of the 
numerous possibilities currently suspected, the involvement of free radicals or their 
metabolites is increasingly recognised. In this regard, administration of 8-epi-
prostaglandin F2a. has been shown to cause significant renal vasoconstriction, causing 
reductions in GFR of between 40-45% in rats 57. Besides, male normotensive Sprague-
Dawley rats aged 22 month have been shown to have a 60% lower GFR and a 3-fold 
higher renal 8-epi-prostaglandin F2a. concentration when compared to 3 to 4 month old 
rats 58. In the same study, supplementation of vitamin E was shown to prevent the drop in 
GFR and at the same time was also accompanied by a 60% reduction in renal 8-epi-
prostaglandin F2a. concentration. It appears the 8-epi-prostaglandin F2a increases not only 
with hypertension but also with age. It is both a marker of free radical activity, and by 
itself, it also has vasoconstrictor activity. However, it is also not possible to say if the 
lowered GFR in the SHR was due to the vasoconstrictor effects of 8-epi-prostaglandin 
F2a and its toxic effects on the renal glomeruli or both. 
In conclusion, this study further confirms that oxidative stress per se may not be directly 
involved in the aetiology of hypertension in SHR, as increased qxidative stress is only 
detectable a few weeks after the establishment of blood pressure in this species. It 
however, does not exclude a possible increase in free radical production before the 
evident oxidative stress. It further confirms that impaired renal function occurs in SHR, 
. but it only becomes apparent at the age of about 28 weeks following a large saline 
challenge. Although it does not provide any direct evidence to show that renal 
impairment in hypertension is due to increased oxidative stress, the time interval between 
the establishment of hypertension and evidence for increased oxidative stress and the 
emergence of renal impairment seem to suggest a role for free radicals in renal 
impairment of hypertension. Clearly more work is still required to ascertain the role of 
free radicals in hypertension and hypertensive renal disease, an understanding of which 
would certainly help in improving the current management of human hypertension and in 
the reduction of its morbidity and mortality. 
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